Piper Sandler reiterated a "neutral" rating and issued a $115.00 price objective on shares of Biogen...
UCB SA (OTC:UCBJY) (OTC:UCBJF) (Euronext Brussels: UCB) and Biogen Inc. (NASDAQ:BIIB) on Thursday pr...
Wedbush reaffirmed a "neutral" rating and issued a $121.00 target price on shares of Biogen in a rep...
Analysts' ratings for Biogen (NASDAQ:BIIB) over the last quarter vary from bullish to bearish, as pr...